Bringing the Future of Cell & Gene Therapies with ScaleReady

1 July 2021
Biotechne, Fresenius Kabi and WilsonWolf present their collaborative new manufacturing platform ScaleReady.

PLAY VIDEO ABOVE * ScaleReady, the sponsor of this content would like to send you information about their products and services. If you do not wish to receive these emails, click here to opt out.

In this demo video, the team behind the development of ScaleReady describe how this novel platform helps customers scale their programs from early stages into clinical and commercial settings, by providing quality and reproducibility at both small bench-top stages or in a large scale bioreactor.

‘Our mission at ScaleReady is to help make the business of cell and gene therapy practical and viable, by providing out customers with the most simple, scalable and versatile manufacturing platform in the industry.”

Phacilitate member? Watch this video and join the conversation via the network.

Not yet a member?
Join Today.